Safety of Oral Midazolam as a Perioperative Anxiolytic for Outpatient Dermatologic Procedures.
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Surgery"
DOI: 10.1097/dss.0000000000002624
Abstract: BACKGROUND Perioperative anxiety can negatively impact patient satisfaction and can complicate outpatient dermatologic procedures. OBJECTIVE Evaluate adverse events associated with oral midazolam as a perioperative anxiolytic during dermatologic surgery and assess whether an enhanced monitoring… read more here.
Keywords: outpatient dermatologic; adverse events; dermatologic procedures; oral midazolam ... See more keywords